GLORIA

GEOMAR Library Ocean Research Information Access

Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
Filter
  • Andrianova, Ekaterina A.  (2)
Material
Person/Organisation
Language
Years
  • 1
    In: Problems of Endocrinology, Endocrinology Research Centre, Vol. 63, No. 1 ( 2017-02-04), p. 17-22
    Abstract: Rationale. Arkray blood glucose meters have become widely used in Russia since 2013. Studies focused on their accuracy, where Arkray Glucocard II glucose meter is used as the reference monitoring system, have been published. Since insulin dose to be injected relies upon readings of a personal blood glucose meter, the system being used must comply with the clinical safety and analytical accuracy criteria for glucose meters. Objective — to assess clinical safety and analytical accuracy of the results of studying blood glucose level measured using Glucocard Sigma and Glucocard Sigma Mini blood glucose meters. Material and methods. Glucose level in a drop of capillary blood was studied in 48 pediatric and adolescent patients with type 1 diabetes mellitus (DMT1). The mean age of the patients was 9.4±5.6 years; average duration of the disease, 4.2±2.7 years. Parallel studies on glycaemia using the Glucocard Sigma and Glucocard Sigma Mini glucose meters being tested, as well as a BIOSEN C-line stationary biochemical analyzer system, were carried out at the Department of Diabetes Mellitus of the Institute of Pediatric Endocrinology and the Biochemical Laboratory of the Endocrinology Research Center of the Ministry of Healthcare of the Russian Federation. A total of 320 samples were examined. The hexokinase method performed on a BIOSEN C-line biochemical analyzer system was used as the reference method for measuring blood glucose level. Results. Assessment of clinical safety demonstrated that 100% of test results belonged to zone A (will not result in patient error) and B (will not result in patient error or there will be a minor error not affecting patient’s condition). These findings fully comply with the ISO 15197-2016 standard. Investigation of the analytical accuracy of Glucocard Sigma and Glucocard Sigma Mini glucose meters (capillary blood, glucose blood level 〉 4.2 mmol/L) compared to the results obtained using the BIOSEN C-line biochemical analyzer system showed a 〈 5% deviation in 118 (51.3%) measurements; 〈 10%, in 202 (87.8%) measurements; less than 15%, 222 (96.5%) measurements; and less than 20%, in 230 (100%) measurements. These results comply both with the ISO 15197-2015 criteria and stricter criteria ISO 15197-2016. Conclusion. The high accuracy of Glucocard Sigma and Glucocard Sigma Mini glucose meters has been confirmed. The accuracy of these glucose meters complies with the State Standard GOST ISO 15197-2015 and the ISO 15197-2016 standard.
    Type of Medium: Online Resource
    ISSN: 2308-1430 , 0375-9660
    URL: Issue
    Language: Unknown
    Publisher: Endocrinology Research Centre
    Publication Date: 2017
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 2
    Online Resource
    Online Resource
    Endocrinology Research Centre ; 2018
    In:  Problems of Endocrinology Vol. 64, No. 2 ( 2018-05-15), p. 116-120
    In: Problems of Endocrinology, Endocrinology Research Centre, Vol. 64, No. 2 ( 2018-05-15), p. 116-120
    Abstract: MODY3 is one of the most common subtypes of MODY. Obesity in MODY3 patients modifies the disease course and complicates diagnostics at the clinical stage. A proband was diagnosed with type 2 diabetes mellitus (T2DM) at the age of 12 years; metformin therapy was used. A family history of DM involves three generations: the mother, aunt, and maternal grandfather have suffered from insulin-dependent DM since the age of 23, 22, and 40 years, respectively. The patient was examined at the age of 14 years. Obesity was present (SDS BMI 2.3). The insulin and C-peptide levels were 4.4 μU/mL and 1.5 ng/mL, respectively. The HbA1c level was 7.3%. Under glucose load, glycemia reached diabetic values; hyperinsulinemia and insulin resistance were not detected. Specific pancreatic antibodies were absent. Metformin was discontinued, and a sulfonylurea (SU) drug was prescribed, which had a positive effect. The heterozygous mutation p.P291fs was identified in the HNF1A gene. Therefore, MODY3 was verified. The presence of concomitant obesity in the patient significantly complicates the differential diagnosis, and only a careful comprehensive analysis of clinical and laboratory parameters and a family history makes it possible to suspect the diagnosis of MODY3 (requiring subsequent molecular genetic verification) and prescribe pathogenetic therapy.
    Type of Medium: Online Resource
    ISSN: 2308-1430 , 0375-9660
    URL: Issue
    Language: Unknown
    Publisher: Endocrinology Research Centre
    Publication Date: 2018
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. More information can be found here...